Ranbaxy Laboratories Ltd: Recent News and Job Opportunities - Printable Version
+- Biotechnology Forums (https://www.biotechnologyforums.com)
+-- Forum: Information (https://www.biotechnologyforums.com/forum-16.html)
+--- Forum: Companies and Latest Innovations (https://www.biotechnologyforums.com/forum-11.html)
+--- Thread: Ranbaxy Laboratories Ltd: Recent News and Job Opportunities (/thread-2338.html)
Ranbaxy Laboratories Ltd: Recent News and Job Opportunities - SunilNagpal - 07-05-2013
Ranbaxy is a world renowned Pharmaceutical company (serving over 150 Nations), with it's global headquarters in Gurgaon, Haryana (India). With it's diverse portfolio of Generics, Branded Generics, Value-added and Over-the-Counter (OTC) products, Anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), Vaccines etc, Ranbaxy has a strong hold in the pharmaceutical markets of both the developed and developing nations. Since it's inception in 1961, Ranbaxy has given due consideration to Research and Innovation, enabling it to consistently add depth to it's product pipeline.
Here's a brief overview of the recent updates and job positions at Ranbaxy.
The Bombay Stock Exchange (BSE) has been informed recently by Ranbaxy that it's Quarter 2 (Q2) results will be declared on August 7, 2013. A meeting of the Board of Directors of the Company will be held on the declared date to shed consideration on Standalone and Consolidated Unaudited Financial Results of Q2, as well as the ended half year (till June 30, 2013).
Click here for the stock report
Click here for the details
In a bid to expand the businesses, Ranbaxy and Daiichi Sankyo have entered into a synergy to launch a hybrid business in Brazil. Ranbaxy will enter the branded generics market of Brazil with this synergism, and for that it will support Daiichi Sankyo Brasil Farmaceutica Ltda, Brazilian subsidiary of Daiichi Sankyo.
Click here for details
Following are the recent Job Openings at Ranbaxy, India:
(To apply, Click here)
We will keep updating the post.
Thanks for Reading!
RE: Ranbaxy Laboratories Ltd: Recent News and Job Opportunities - priyasaravanan_1406 - 08-14-2013
Award to Ranbaxy Laboratories for its innovation of the anti malarial drug Synriam TM
Date : 16 July 2013
Name of the Award: "Innovation Excellence Platinum Award"
Occasion: ASSOCHAM Innovation Awards 2013
Category: Science and Technology
For the Innovation : New, first of its kind anti malarial drug Synriam TM
About ASSOCHAM Innovation Awards :
ASSOCHAM Innovation Awards serves the motto of identifying innovative organization in India and show cases their excellence in innovation by awarding the organization. So that the organization awarded for excellence will be a trend setter to all the other organizations.
About Synriam TM:
Credit : New anti malarial drug, first of its kind.
Market Entry: World Malarial day 25th April 2012
Purpose: To treat adults infected with Plasmodium falciparum a causative agent of Malaria
Synriam TM: Combination of Arterolane maleate 150 and Piperaquine phosphate 750mg.
Mode of Action:
Arterolane maleate – Acts against the malarial parasite in the blood of the infected person
Piperaquine Phosphate – Acts against the residual malarial parasite and ensures non occurrence of another malarial episode in the treated patient.
Dosage : one tablet per day for 3 days
Targeting the drug markets in Africa, Asia and South America
Ranbaxy is preparing to submit a New drug application proposal to gain the market authorization for the drug Synriam in African regions for the year 2013.
Clinical trials under progress to make this drug available for children in the malarial episode areas in Asia and Africa
Total Number of tablets sold: 2 million
Number of patients cured in India: 7,00,000
Production Feasibility: As this drug is of synthetic origin it can be produced in large scales as and when required without any hurdle.
Ranbaxy owns the rights for this product and IP for this drug is protected till the year 2022
The drug Synriam TM has also secured Golden Peacock Innovative product / Service Award.